Metropolitan Digital

Men's Weekly


.

China's win-at-all-costs approach suggests it will follow its own dangerous path in biomedicine

  • Written by Hallam Stevens, Associate Professor of History, Nanyang Technological University
China's win-at-all-costs approach suggests it will follow its own dangerous path in biomedicineMegacity Shenzhen, as seen from Hong Kong, is a center for Chinese finance and tech.AP Photo/Kin Cheung

The world was shocked by Chinese scientist He Jiankui’s recent claim that he’d brought to term twin babies whose genes – inheritable by their own potential descendants – he had modified as embryos. The genetic edit, He...

Read more: China's win-at-all-costs approach suggests it will follow its own dangerous path in biomedicine

Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more